We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Commentary: Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysis.
- Authors
Zhang, Ina; Jansen, Jeroen P.; Yungher, Benjamin J.; Kielhorn, Adrian; Yee, Karen S.
- Abstract
This document is a commentary on a research article that examines the effectiveness and safety of monoclonal antibodies in adults with generalized myasthenia gravis. The commentary points out limitations in the research article, such as the definition of the target population and the inclusion of relevant trials. It also emphasizes the importance of considering treatment effect modifiers and the timing of outcome assessments in network meta-analysis. The commentary highlights the need for clear definitions and detailed considerations to ensure the clinical relevance and credibility of the findings. The given text is a list of references and citations from various sources related to the treatment of generalized myasthenia gravis, providing information about different drugs, therapies, clinical trials, and meta-analyses.
- Subjects
MYASTHENIA gravis; BAYESIAN analysis; MONOCLONAL antibodies; ADULTS; EMPLOYEE ownership
- Publication
Frontiers in Immunology, 2024, p1
- ISSN
1664-3224
- Publication type
Article
- DOI
10.3389/fimmu.2024.1403802